AbstractSmall cell carcinoma (SmCC) of the prostate is a very rare and aggressive type of prostatic cancer. It is hard to early diagnose and most cases are diagnosed at advanced stage. The bones, liver, regional and distant lymph nodes are the most common sites of metastasis. The treatment for SmCC of the prostate is different from that of acinar adenocarcinoma. While chemotherapy is suggested, there is no standard regimen, let alone personalized strategy. Additionally, hormone therapy does not often work for this type of prostate cancer. Here, we report a rare case of SmCC of the prostate who initially presented with lower cervical spine radiculopathy
AbstractBackgroundThe intent of this study was to explore the treatment efficacy of erlotinib, pemet...
AbstractThymoma is associated with a wide variety of paraneoplastic syndromes such as myasthenia gra...
AbstractWith the growing use of immunotherapy in the treatment of cancer and autoimmune disease, sev...
AbstractSarcomatous hepatocellular carcinoma (HCC) is a rare subtype of hepatoma, along with worse p...
AbstractLung cancer is the leading cause of death from cancer worldwide. Almost 60% of patients with...
AbstractPrimary hepatic adenosquamous carcinoma (ASC), a variant cholangiocellular carcinoma (CCC) s...
AbstractRenal cell carcinoma (RCC) is a highly lethal genitourinary malignancy due to infrequent ear...
AbstractBackgroundHemophagocytic lymphohistiocytosis (HLH) is a rare disease with high fatality. It ...
AbstractGiant cell tumor (GCT) is a benign but locally aggressive skeletal neoplasm of young adults....
AbstractTrastuzumab, a humanized monoclonal antibody directed against the external domain of the HER...
AbstractAmeloblastomas are benign but locally invasive odontogenic epithelial tumors. They have a hi...
AbstractThe incidence of double primary malignancy in colorectal cancer is rare (approximately 1-6%)...
在美國,攝護腺癌是男性常見癌症之一。在台灣,攝護腺癌的發生率有逐年上升現象,且在2008年行政院衛生署癌症發生統計中,排名第七。隨著攝護腺癌病期演進,癌細胞常惡性轉移至淋巴結或骨頭,造成癌症治療困難。...
AbstractThe leading cause of death from malignant tumors worldwide is lung cancer. Before the develo...
AbstractIfosfamide is an alkylating antineoplastic prodrug used to treat many solid tumors. The meta...
AbstractBackgroundThe intent of this study was to explore the treatment efficacy of erlotinib, pemet...
AbstractThymoma is associated with a wide variety of paraneoplastic syndromes such as myasthenia gra...
AbstractWith the growing use of immunotherapy in the treatment of cancer and autoimmune disease, sev...
AbstractSarcomatous hepatocellular carcinoma (HCC) is a rare subtype of hepatoma, along with worse p...
AbstractLung cancer is the leading cause of death from cancer worldwide. Almost 60% of patients with...
AbstractPrimary hepatic adenosquamous carcinoma (ASC), a variant cholangiocellular carcinoma (CCC) s...
AbstractRenal cell carcinoma (RCC) is a highly lethal genitourinary malignancy due to infrequent ear...
AbstractBackgroundHemophagocytic lymphohistiocytosis (HLH) is a rare disease with high fatality. It ...
AbstractGiant cell tumor (GCT) is a benign but locally aggressive skeletal neoplasm of young adults....
AbstractTrastuzumab, a humanized monoclonal antibody directed against the external domain of the HER...
AbstractAmeloblastomas are benign but locally invasive odontogenic epithelial tumors. They have a hi...
AbstractThe incidence of double primary malignancy in colorectal cancer is rare (approximately 1-6%)...
在美國,攝護腺癌是男性常見癌症之一。在台灣,攝護腺癌的發生率有逐年上升現象,且在2008年行政院衛生署癌症發生統計中,排名第七。隨著攝護腺癌病期演進,癌細胞常惡性轉移至淋巴結或骨頭,造成癌症治療困難。...
AbstractThe leading cause of death from malignant tumors worldwide is lung cancer. Before the develo...
AbstractIfosfamide is an alkylating antineoplastic prodrug used to treat many solid tumors. The meta...
AbstractBackgroundThe intent of this study was to explore the treatment efficacy of erlotinib, pemet...
AbstractThymoma is associated with a wide variety of paraneoplastic syndromes such as myasthenia gra...
AbstractWith the growing use of immunotherapy in the treatment of cancer and autoimmune disease, sev...